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Are you lost in the intricate
signaling networks that mediate
‘checkpoint’ responses which act
to preserve genome integrity in
the face of DNA damage? It would
not be surprising if you were,
given the complexity of these
networks. But help should come
from recent studies in budding
yeast which have shed some new
light on the mechanism of
activation of the Rad53 kinase.
Using powerful proteomic
approaches, Smolka et al. [1] and
Sweeney et al. [2] have
succeeded in mapping and
characterizing the
phosphorylation residues of the
Rad53 kinase (Figure 1), revealing
how the sensor PIKK — PI (3)
kinase-like kinase — checkpoint
kinases activate and modulate the
Rad53-like effector kinases.
Rad53 was initially identified in
1991 [3] in a biochemical screen
as a serine/threonine/tyrosine
kinase, but became soon known
as a key guardian of genome
integrity [4]. We now know that
the Rad53 family members, which
include the Chk2 protein in human
cells, play a central role in the
signal transduction pathway that
is activated in response to DNA
lesions and helps to prevent
genome rearrangements and
cancer [5].
At present, the mechanisms
leading to activation of the so-
called ‘genome integrity
checkpoints’ are best understood
in the model yeast species
Saccharomyces cerevisiae and
Schizosaccharomyces pombe.
Briefly, the DNA damage-induced
formation of single-stranded DNA
regions coated by RP-A trigger
the recruitment of checkpoint
sensors such as the PIKK Mec1 in
budding yeast (or ATR in human
cells) [6]. In addition, a number of
checkpoint factors, including
Rad9, associate with the sites of
damaged DNA and are
phosphorylated by Mec1 [7].
However, an important issue still
awaits elucidation, and that is how
the initial checkpoint response to
DNA damage is finally amplified to
a global cellular response which
ultimately results in cell cycle
delay, DNA repair and, in higher
eukaryotes, in the apoptotic
program [5], or even in the
activation of the innate immune
response that leads to the
elimination of damaged cells [8].
From the observation that
overexpression of Rad53 kinase in
bacteria results in its
autophosphorylation and
activation in the absence of DNA
damage, Lowndes and collaegues
[9] proposed that Rad53 might be
activated simply by processes that
facilitate a local increase in its
concentration. This was confirmed
by hydrodynamic analysis of
protein complexes isolated from
UV-treated cells, which showed
that the Rad9 protein acts as a
scaffold for concentrating Rad53
(Figure 2A). Following in trans
autophosphorylation, the Rad53
kinase is released from the Rad9
complex, thus amplifying the alarm
signal throughout the cell [9]. 
The solid-state catalyst model
proposed for Rad53 activation [9]
does not, however, explain the
role of PIKKs in Rad53 signaling,
whereas the observation that
Mec1 mediates the in trans
phosphorylation of a kinase
defective Rad53 protein clearly
indicates PIKKs are involved [10].
Further, although Rad53
undergoes autophosphorylation
events even in in situ renaturation
kinase assays — ruling out the
involvement of putative
associated limiting factors
required for the catalytic reaction
— this reaction still requires the
presence of functional Mec1 and
Rad9 proteins [10].
Using mass spectrometry
based methods, Smolka et al. [1]
and Sweeney et al. [2] have
determined the phosphorylation
sites of Rad53 in yeast cells
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Recent studies have elucidated the activation mechanism of the Rad53
checkpoint kinase and the role of Rad9-like adaptor proteins in
mediating signal transduction from PIKK sensor kinases that detect
DNA damage to the effector kinases that play a part in mending that
damage.
Figure 1. Rad53 phosphorylation sites.
Relevant Rad53 domains are indicated as follows: the gray boxes indicate the S/T-Q
clusters; the green box at the carboxyl-end of the protein represents a bipartite nuclear
localization signal; the red box inside the kinase domain (brown) represents the activa-
tion segment. Proline-directed sites are underlined and bold.
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experiencing DNA damage after
treatment with 4-nitroquinoline
oxide (4-NQO, a UV light mimetic
compound) or methyl
metanesulfonate (MMS),
respectively (Figure 1). Moreover,
by an in vitro kinase assay with
the purified proteins, Sweeney et
al. [2] were able to reconstitute
Mec1-dependent Rad53 signaling,
demonstrating unambiguously
that Mec1 phosphorylates Rad53
even in the absence of the
catalytic activity of the effector
kinase. Intriguingly, the
hyperphosphorylated form of
Rad9 represents a limiting and
essential element for the Mec1-
mediated Rad53 signaling,
supporting the view that Rad9 is
an adaptor required by Mec1 to
target Rad53 molecules
(Figure 2B).
Indeed, the Rad9 protein is a
perfect molecular bridge for
connecting PIKKs and Rad53-like
kinases, as it is itself
phosphorylated by Mec1 at
multiple sites [11,12], and the
Rad9 hyperphosphorylated
segments interact with the two
Rad53 forkhead-associated (FHA)
domains, specialized in targeting
phospho-peptides [13,14].
Considering that the Rad9 protein
is dispensable for Mec1-
dependent-Rad53 signaling in
response to replication blocks
induced by hydroxyurea treatment
[10], it is likely that the Mrc1
protein carries out the adaptor
function under these conditions
[15]. So, it will be of great interest
to confirm the existence of other
Rad9-like PIKK-adaptor factors,
not only in yeast cells, but also in
higher eukaryotes, where the
PIKK-dependent networks are
certainly much more complex
than those of yeast cells [16].
Impressively, the Rad53 protein
turns out to be phosphorylated at
more than twenty residues
(Figure 1) and, whereas a number
of them are generated by
autophosphorylation events, as
demonstrated by Sweeney et al.
[2], many others result from in
trans phosphorylation mediated
by apical kinases. As previously
anticipated [17], most of the in
trans phosphorylated sites are
located in S/T-Q clusters, the
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Figure 2. Models for Rad53 activation.
(A) The solid-state catalyst model proposed by Lowndes and colleagues [9]. Hyperphosphorylation of Rad9 molecules (dark blue)
results in the recruitment of Rad53 protein kinase (yellow). Rad53 molecules are thus concentrated, facilitating in trans autophos-
phorylation reactions. The small black round shapes indicate the phospho-residues. Autophosphorylation of Rad53 results in its
release and transition into the active state (green). Inactive Rad53 molecules (red) are then re-cycled to form pre-active Rad9-Rad53
complexes. (B) The adaptor-based model proposed by Durocher and colleagues [2]. Mec1-dependent hyperphosphorylation of Rad9
protein (step 1) promotes the recruitment of inactive Rad53 protein. Mec1 then phosphorylates Rad53 (step 2) which undergoes
through autophosphorylation (step 3) and release from Rad9. (C) The adaptor-catalyst model. Mec1 phosphorylates Rad9 protein
(step 1) at multiple sites. A threshold of Rad9 phosphorylation is required to recruit and phosphorylate Rad53 at multiple sites (step
2). Rad53 then undergoes autophosphorylation: Rad9 oligomerizes and facilitates Rad53 in trans autophosphorylation (step 3) by
increasing the local concentration of Rad53 molecules. Active Rad53 kinases are then released from the complex.
Active Rad53
A
Inactive Rad53
Pre-active Rad53-Rad9 complex
Rad53 release
Inactive Rad53
Mec1
B
Rad9
1
2
3
Rad53 release
Active Rad53
Pre-active Mec1-Rad9-Rad53 complex
2
C
Rad9
Mec1
Inactive Rad53
1
3
Rad53 release
Pre-active Mec1-Rad9-Rad53 complex
2
Active Rad53
Current Biology
typical consensus for PIKKs.
Further, both studies [1,2] found
proline-directed phosphorylated
sites in Rad53, suggesting that
the cell cycle kinase CDK1 might
directly modulate Rad53 activity,
as also supported by recent
observations implicating CDK1 in
checkpoint activation [18].
We note that the DNA damage-
dependent phospho-residues
found by the two studies [1,2] do
not always overlap (Figure 1). In
particular, Smolka et al. [1] found
phospho-residues in the S/T-Q
cluster at the amino-terminal part
of Rad53 in cells damaged with
MMS, whereas the same sites
were not identified by Sweeney
et al. [2] in cells treated with 4-
NQO (Figure 1). An attractive
hypothesis is that, depending on
the nature of the primary DNA
lesions, the in trans
phosphorylation by PIKKs is
required not only to activate
Rad53, but also to direct the
active form of the kinase to the
appropriate signaling pathway, by
creating specialized phospho-
interfaces in the Rad53 protein.
Indeed, the genetic requirements
influencing Rad53 activation in
response to MMS or 4-NQO are
different [10,19].
Considering that Rad53 and
Rad9 are phosphorylated at
multiple sites, the two models for
Rad53 activation may not be
necessarily exclusive
(Figure 2A,B) and could be
reconciled in a stepwise model in
which Rad9 acts both as an
adaptor mediating the interaction
between Mec1 and Rad53 and as
a scaffold protein facilitating the
concentration of Rad53 molecules
(Figure 2C).
Once again, phosphorylation at
multiple sites emerges as a
common strategy in kinase-based
signal transduction processes.
This mechanism of activation, in
theory, would be ideal to avoid
futile activation of the pathway
when the signal is below a certain
threshold. Further, the
redundancy of phospho-sites
represents a warranty for the cell
against mutations on those
residues, as the inactivation of
one of these sites should not
necessarily impair the
transduction cascade.
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Voltage-gated potassium (Kv)
channels are potassium selective
ion channels which are activated
by a change in transmembrane
voltage. They play a key role in
the physiology of excitable cells
[1], and are related to voltage-
gated sodium and calcium
channels. Thus, an understanding
of the mechanism of Kv channels
will also inform our understanding
of sodium and calcium channels,
as illustrated by the recently
reported crystal structure of a
mammalian voltage-gated
potassium channel [2].
Potassium Channels: Complete
and Undistorted
The recently determined structure of a mammalian voltage-gated
potassium channel has important implications for our understanding of
voltage-sensing and gating mechanisms in channels. It is also the first
crystal structure of an overexpressed eukaryotic membrane protein.
